Przeglądaj według tematu "Immunotherapy"
Wyświetlanie pozycji 1-1 z 1
-
Gut microbial predictors of firstline immunotherapy efficacy in advanced NSCLC patients
(Nature, 2025)The composition of the gut microbiome of patients with advanced non-small cell lung cancer is currently considered a factor influencing the effectiveness of treatment with immune checkpoint inhibitors. We aimed to evaluate ...